Australia's Biotech Challenge

Business Asia, March 2001 | Go to article overview

Australia's Biotech Challenge


Australia's biotechnology industry is at the forefront of international development and research, but do we have the nous to make this industry a commercial success? NADIA CAMERON looks at the changing face of Australia's biotechnology sector.

A LACK OF commercial skills could cost Australia a position as a future biotechnology leader, industry experts say.

According to the country's leading biotech authorities, Australia has the research skills and talent to outshine the competition, but when it comes to establishing viable, commercial products, we're well behind the eight ball.

Australia's tack of commercial finesse could be the greatest hurdle in its quest to secure a position in the global biotechnology sector. Although still a relatively new industry, global biotechnology companies are finding that success depends not only on the ability to develop and research, but also on the ability to market findings into useful, commercial products. And with the world biotech industry estimated to be worth US$200 billion ($393 billion), Australia cannot afford to miss out.

Biotechnology is being heralded as the next big knowledge industry. In its broadest sense, it encompasses a group of technologies based on improving biological processes. Biotechnology has a diverse impact across several sectors, including human health, agriculture, food processing, manufacturing and environmental management.

Companies involved in biotech are also widely varied, and can be anyone from those who conduct research and development of products and processes, to the suppliers for these firms. In Australia's case, efforts are concentrated in five main areas, with human health the main study of 34 per cent of biotech companies. Agriculture is the second highest, with 23 per cent of Australian companies directing their research into this area in 1999. Australia's other areas of expertise are in equipment and services (12 per cent), environmental (11 per cent), and food production and processing (10 per cent).

Australia's contribution to the global biotech sector, while small, is well respected through the achievements of internationally recognised companies such as Cochlear, Biota and CSL.

The total revenue of Australia's biotechnology industry was estimated at $965 million in 1998/99, with just over $800 million direct from product sales.

There are approximately 150 dedicated biotech companies now operating in Australia, with 47 listed on the Australian Stock Exchange and contributing to a combined $12 billion in market capitalisation. This is significantly less than in the US or Europe, which both now exceed 1000 companies each and generate over US$22 billion in revenue combined.

Despite the massive size differences, industry representatives say Australia has the potential to become a global leader in the future, provided it nurtures its biotech industry and develops its commercially.

Dr Tim Littlejohn, chief scientific officer at Entigen, has confidence in Australia's biotechnology sector. He says there are plenty of opportunities for the industry to develop.

"My view of Australia's biotech industry is that it is full of dynamic players," he said.

"We've got tremendous life research and a good health care sector, and if you couple all of those together in conjunction with our position, our life sciences, our information technology expertise and our linkages to the rest of the world, we're ripe for a booming biotechnology industry."

Entigen, who specialise in the field of bioinformatics, are well aware of Australia's need for capitalising on its research. The role of bioinformatics, Littlejohn says, is to take the "wash of raw data" which stems from biotech research and turn it into information which is both manageable and accessible. By doing this, he believes his company is helping to push biotechnology development into a viable information technology industry. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • A full archive of books and articles related to this one
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Australia's Biotech Challenge
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

    Already a member? Log in now.